President Trump signed an executive order on Monday aimed at slashing prices for prescriptions. However, the actual impact of the order is unclear. Host Peter O'Dowd turns to NPR's pharmaceutical correspondent Sydney Lupkin to break it all down. This segment airs on May 13, 2025. Audio will be available after the broadcast.

President Trump will hold a press conference Monday morning with Health and Human Services Secretary Robert F. Kennedy Jr. to announce an executive order to cap prescription drug and pharmaceutical prices at the lowest cost offered in any other country.

The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first administration.

The editorial board of the Wall Street Journal is criticizing President Trump over an executive order expanding drug price controls. “For that trade we could have elected Democrats,”